Clinical trials of a whole range of anti-Ebola drugs will be held in Congo
The Congo authorities approved four clinical trials to combat with Ebola. Researches help to collect the necessary data to evaluate the effectiveness of medicines.
Since 1975, 10 outbreaks of Ebola have been recorded in the Congo, the last one was identified this year as the largest of the hole observation period. Congolese doctors have been using experimental drugs in clinical practice since August to fight a fever. Now, their use will be regulated by the study protocol.
All four experimental drugs are monoclonal antibodies mAb114, they are similar in structure to antibodies to the Ebola virus, obtained from the blood of an African who has had this infection.
Cases of Ebola were recorded in the Congo province of North Kivu since April of this year. In the summer, the situation worsened after the infection was brought to the neighboring province of Ituri. In this area, the elimination of the outbreak is hampered by the ongoing clashes between local militias.